IL222642A0 - Formulations and uses of 2-hydroxy-5-phenylazobenzoic acid derivatives for the treatment of males - Google Patents

Formulations and uses of 2-hydroxy-5-phenylazobenzoic acid derivatives for the treatment of males

Info

Publication number
IL222642A0
IL222642A0 IL222642A IL22264212A IL222642A0 IL 222642 A0 IL222642 A0 IL 222642A0 IL 222642 A IL222642 A IL 222642A IL 22264212 A IL22264212 A IL 22264212A IL 222642 A0 IL222642 A0 IL 222642A0
Authority
IL
Israel
Prior art keywords
males
formulations
hydroxy
treatment
acid derivatives
Prior art date
Application number
IL222642A
Other languages
English (en)
Original Assignee
Salix Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=44861888&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL222642(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Salix Pharmaceuticals Ltd filed Critical Salix Pharmaceuticals Ltd
Publication of IL222642A0 publication Critical patent/IL222642A0/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/655—Azo (—N=N—), diazo (=N2), azoxy (>N—O—N< or N(=O)—N<), azido (—N3) or diazoamino (—N=N—N<) compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)
IL222642A 2010-04-26 2012-10-23 Formulations and uses of 2-hydroxy-5-phenylazobenzoic acid derivatives for the treatment of males IL222642A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US32815110P 2010-04-26 2010-04-26
PCT/US2011/033905 WO2011137103A1 (en) 2010-04-26 2011-04-26 Formulations and uses of 2-hydroxy-5-phenylazobenzoic acid derivatives for the treatment of males

Publications (1)

Publication Number Publication Date
IL222642A0 true IL222642A0 (en) 2012-12-31

Family

ID=44861888

Family Applications (1)

Application Number Title Priority Date Filing Date
IL222642A IL222642A0 (en) 2010-04-26 2012-10-23 Formulations and uses of 2-hydroxy-5-phenylazobenzoic acid derivatives for the treatment of males

Country Status (9)

Country Link
US (3) US8497256B2 (enExample)
EP (1) EP2563117B1 (enExample)
JP (1) JP2013525440A (enExample)
AU (1) AU2011245455A1 (enExample)
BR (2) BR122014009845A2 (enExample)
CA (1) CA2797560A1 (enExample)
IL (1) IL222642A0 (enExample)
MX (1) MX358142B (enExample)
WO (1) WO2011137103A1 (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2021528385A (ja) 2018-06-05 2021-10-21 フラッグシップ パイオニアリング イノベーションズ ブイ， インコーポレイテッド 自己免疫障害を治療するためのアシル化活性剤およびその使用方法

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US326364A (en) 1885-09-15 Electric-lamp hanger
US4298595A (en) 1978-12-20 1981-11-03 Dynapol Pharmaceutical preparations containing a polymeric agent for releasing 5-aminosalicylic acid or its salts into the gastrointestinal tract
EP0439453B1 (en) 1987-10-12 1994-01-19 Exomed Australia Pty. Ltd. (ACN 051 976 446) Improved method for treatment of gastrointestinal disorders
US5443826A (en) 1988-08-02 1995-08-22 Borody; Thomas J. Treatment of gastro-intestinal disorders with a fecal composition or a composition of bacteroides and E. Coli
US5519014A (en) 1990-10-22 1996-05-21 Borody; Thomas J. Treatment of non-inflammatory and non-infectious bowel disorders
US5498608A (en) 1994-01-07 1996-03-12 Salix Pharmaceuticals Use of 2-hydroxy-5-phenylazobenzoic acid derivatives as colon cancer chemopreventative and chemotherapeutic agents
US5905073A (en) 1995-01-06 1999-05-18 Salix Pharmaceuticals, Inc. Use of 2-hydroxy-5-phenylazobenzoic acid derivatives as colon cancer chemopreventative and chemotherapeutic agents
SE9700934D0 (sv) 1997-03-14 1997-03-14 Astra Ab New formulation
US6551632B2 (en) 1997-04-01 2003-04-22 Thomas Julius Borody Methods and compositions for treating inflammatory bowel disease
DE69839261T2 (de) 1997-04-01 2009-03-26 Borody, Thomas Julius, Five Dock Verfahren und zusammensetzungen zur behandlung entzündlicher darmerkrankungen
AUPO665397A0 (en) 1997-05-07 1997-05-29 Borody, Thomas Julius Novel therapy for constipation
AUPP437698A0 (en) 1998-06-30 1998-07-23 Baumgart, Karl Methods for treatment of coronary, carotid and other vascular disease
US6326364B1 (en) 1999-02-08 2001-12-04 Cedars-Sinai Medical Center Use of 5-aminosalicylates as antimicrobial agents
EP2529729A1 (en) 2005-08-24 2012-12-05 Salix Pharmaceuticals, Inc. Balsalazide formulations and manufacture thereof
US7452872B2 (en) * 2005-08-24 2008-11-18 Salix Pharmaceuticals, Inc. Formulations and uses of 2-hydroxy-5-phenylazobenzoic acid derivatives
US8921344B2 (en) * 2006-11-03 2014-12-30 Salix Pharmaceuticals, Inc. Formulations and uses of 2-hydroxy-5-phenylazobenzoic acid derivatives
US20100048519A1 (en) 2006-09-13 2010-02-25 Chyon-Hwa Yeh Methods of treatment for ulcerative colitis using aminosalicylate

Also Published As

Publication number Publication date
BR112012027520A2 (pt) 2015-09-15
EP2563117A1 (en) 2013-03-06
WO2011137103A1 (en) 2011-11-03
US20120058184A1 (en) 2012-03-08
EP2563117A4 (en) 2013-09-04
US20130295178A1 (en) 2013-11-07
JP2013525440A (ja) 2013-06-20
CA2797560A1 (en) 2011-11-03
US8497256B2 (en) 2013-07-30
US20150132381A1 (en) 2015-05-14
EP2563117B1 (en) 2018-02-21
BR122014009845A2 (pt) 2015-12-29
MX2012012324A (es) 2013-01-29
MX358142B (es) 2018-08-06
AU2011245455A1 (en) 2012-11-15

Similar Documents

Publication Publication Date Title
EP2486061A4 (en) COMPOSITIONS AND METHODS FOR THE TRANSPORT OF THERAPEUTICS
IL250259B (en) Preparations containing ursolic acid or its derivative and their uses
LT2596786T (lt) Eikozapentaeno rūgšties etilo esterio naudojimas hipertriglicidemijai gydyti
EP2552433A4 (en) COMPOSITIONS AND METHODS OF TREATING SOMATOSENSORY DISEASES
ZA201308086B (en) Derivatives of 1-anino-2-cyclopropylboronic acid
IL224544B (en) Compound useful for the treatment of nonsense-mutation-mediated diseases and pharmaceutical composition comprising said compound
IL215592A0 (en) Compositions and methods for the treatment of inflammation
PL2552449T3 (pl) Kompozycje zawierające brymonidynę do leczenia rumienia
IL225793A0 (en) Methods and preparations for curing insulin-related medical conditions
IL230547A (en) Formulations of deoxycholic acid and saline
EP2619194A4 (en) CATECHIN FATTY ACID DERIVATIVES AND METHODS OF USE
EP2636666A4 (en) TRANS-2 DECENTRIC ACID DERIVATIVES AND MEDICAMENTS CONTAINING THEREOF
HUE046047T2 (hu) Dezoxikólsavat és sóit tartalmazó készítmények
IL200753A (en) Pharmaceutical preparation containing ib – meca for the treatment of psoriasis
HRP20211496T8 (hr) Uređaji za liječenje ozljeda kože
ZA201208775B (en) Gel formulations for the topical use of 1-amino-alkycyclohexane derivatives
PT2460509T (pt) Composição para tratamento de verrugas
HU1000343D0 (en) Use of kynurenic acid amide derivatives for the treatment of huntington disease
IL222642A0 (en) Formulations and uses of 2-hydroxy-5-phenylazobenzoic acid derivatives for the treatment of males
IL223219A0 (en) Flufenoxine derivatives for the treatment and prevention of amiloyd pathologies
PT2456445E (pt) Agente para o tratamento de condições da pele
ZA201304035B (en) Diarylpyridazinone derivatives,preparation thereof,and use thereof for the treatment of humans
HK1174345A (en) Compositions and methods for the transport of therapeutic agents
AU2010904906A0 (en) Methods and compositions for the treatment and prevention of skin disorders
PL2538922T3 (pl) Formułowanie kompozycji do leczenia stanów zapalnych